EUVIMEDEUVIMED entdecken
Open Access

Inherited Basaloid Neoplasms Associated With SUFU Pathogenic Variants

James J Abbott, Angela J Jiang, Rama Godse, Sarah Ahmed, Stephen C Senft, Melissa A Wilson, Justine V Cohen, Tara C Mitchell, Temitayo A Ogunleye, H William Higgins, Thuzar M Shin, Christopher J Miller und 7 weitere

JAMA Dermatology · 01.11.2024 · 160 (11) · 1220

DOI: 10.1001/jamadermatol.2024.3315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.11.2024. Verfasst von James J Abbott und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Billings Clinic, Billings, Montana. Hauptthemen laut MEDLINE: Skin Neoplasms, Germ-Line Mutation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Germline SUFU pathogenic variants (PVs) have previously been associated with basal cell nevus syndrome (BCNS) and multiple infundibulocystic basal cell carcinoma syndrome; however, a broader spectrum of cutaneous findings in patients with SUFU PVs has not been well delineated.

Objective

To define the clinical and histopathologic spectrum of cutaneous findings in patients with germline SUFU PVs. Design, Setting, and Participants This case series was conducted in multiple US academic dermatology, medical genetics, and medical oncology clinics between July 2014 and July 2022. The study included patients with confirmed germline SUFU PVs who were evaluated by a dermatologist. The analysis took place from March to September 2023. Main Outcomes and Measures Histopathologic evaluation of skin biopsies with or without immunohistochemical staining, and targeted next-generation sequencing (NGS) on tumor specimens.

Results

All 5 patients were women. The mean (range) age at presentation was 50.2 (31-68) years, with skin manifestations initially appearing in the fourth to sixth decades of life. None had keratocystic odontogenic tumors. A total of 29 skin pathology specimens from the 5 patients were reviewed; of these, 3 (10.3%) were diagnosed as basaloid follicular hamartomas (BFHs), 10 (34.5%) classified as infundibulocystic basal cell carcinomas (iBCCs), 6 (20.7%) classified as nodular basal cell carcinomas (nBCCs), and 1 (3.4%) as infiltrative basal cell carcinoma (BCC). Targeted NGS studies on tumor specimens suggest that an increased number of UV-signature variants is associated with basal cell carcinomas compared with more indolent basaloid follicular hamartomas. Conclusions and Relevance Patients with germline SUFU PVs may present with multiple indolent basaloid neoplasms in addition to conventional basal cell carcinomas, typically appearing in the fourth to sixth decades of life. Although there are overlapping clinical manifestations, these findings help to differentiate the clinical syndrome associated with SUFU PVs from PTCH1 BCNS. Awareness of the clinicopathologic spectrum of SUFU -associated basaloid neoplasms is important for dermatologists and dermatopathologists because many (although not all) of these lesions are indolent and do not require aggressive surgical treatment. Importantly, because SUFU lies downstream of the protein smoothened, vismodegib and other smoothened inhibitors are unlikely to be effective therapies in this subset of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsGerm-Line MutationHumansFemaleMiddle AgedAdultAgedRepressor ProteinsBasal Cell CarcinomaHigh-Throughput Nucleotide SequencingBiopsySkinBasal Cell Nevus Syndrome

Substanzen

SUFU protein, humanRepressor Proteins

Autor:innen und Institutionen

  • Department of Dermatology, Billings Clinic, Billings, Montana.
  • Department of Dermatology, Oregon Health and Sciences University, Portland.
  • Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
  • Department of Dermatology, St Luke's University Health Network, Easton, Pennsylvania.
  • Division of Medical Oncology, St Luke's University Health Network, Easton, Pennsylvania.
  • Dana Farber Cancer Institute, Boston, Massachusetts.

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Abbott, J. J., Jiang, A. J., Godse, R., Ahmed, S., Senft, S. C., Wilson, M. A., Cohen, J. V., Mitchell, T. C., Ogunleye, T. A., Higgins, H. W., Shin, T. M., Miller, C. J., Roth, J. J., Priore, S. F., Castelo-Soccio, L., Elenitsas, R., Seykora, J. T., Nathanson, K. L., & Chu, E. Y. (2024). Inherited Basaloid Neoplasms Associated With SUFU Pathogenic Variants. JAMA Dermatology, 160(11), 1220. https://doi.org/10.1001/jamadermatol.2024.3315

Vancouver

Abbott JJ, Jiang AJ, Godse R, Ahmed S, Senft SC, Wilson MA, et al. Inherited Basaloid Neoplasms Associated With SUFU Pathogenic Variants. JAMA Dermatology. 2024;160(11):1220. doi:10.1001/jamadermatol.2024.3315

BibTeX
@article{Abbott2024,
  author = {Abbott, James J and Jiang, Angela J and Godse, Rama and Ahmed, Sarah and Senft, Stephen C and Wilson, Melissa A and Cohen, Justine V and Mitchell, Tara C and Ogunleye, Temitayo A and Higgins, H William and Shin, Thuzar M and Miller, Christopher J and Roth, Jacquelyn J and Priore, Salvatore F and Castelo-Soccio, Leslie and Elenitsas, Rosalie and Seykora, John T and Nathanson, Katherine L and Chu, Emily Y},
  title = {Inherited Basaloid Neoplasms Associated With SUFU Pathogenic Variants},
  journal = {JAMA Dermatology},
  year = {2024},
  volume = {160},
  number = {11},
  pages = {1220},
  doi = {10.1001/jamadermatol.2024.3315}
}
Kostenlos starten →